In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Pfizer marketing UCB's allergy antihistamine Zyrtec

Executive Summary

Pfizer announced FDA approval of Zyrtec, a once-daily allergy pill it had licensed several years back from Belgian drug maker UCB Pharma. Pfizer took the product through US clinical testing and gets US and Canadian marketing rights.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register